Skip to main content

Headache and Pain Management Research

Headache Trials


The Pain Biomarker Study: Changes in circulating pain signaling molecules when pain is provoked

Investigator: Mark Burish, MD

Lead CRC: Rebecca Martinez

Purpose: This study investigates molecular and physical biomarkers of headaches in order to better understand mechanisms of these diseases.

Enrollment Status: Actively enrolling

Contact Us: To learn more about this trial, please fill out this short online form »


Study Name American Registry For Migraine Research

Investigator: Mark Burish, MD

Lead CRC: Rebecca Martinez

Purpose: To collect biospecimens and longitudinal clinical data from research subjects with primary and secondary headache disorders. Observational Study

Enrollment Status: Actively enrolling

Contact Us: To learn more about this trial, please fill out this short online form »


Investigation of Clinical Questionnaires in Cluster Headache

Investigator: Mark Burish, MD

Lead CRC: Rebecca Martinez

Purpose: To determine if one or several questionnaires is useful in the diagnosis of cluster headache.

Key Inclusion Criteria: Retrospective Chart Review Protocol. Exitsing data from pt chart

Status: Ongoing.

Contact Us: To learn more about this trial, please fill out this short online form »


Pain Management Trials


Study Name Discovery of Biomarker Signatures Prognostic for Neuropathic Pain after Acute Spinal Cord Injury

Investigator: Georgene Hergenroeder, PhD

Lead CRC: Lisa Schmitt

Purpose: To develop a biomarker signature prognostic of SCI-induced neuropathic pain. The ultimate goal is to identify new non-addictive treatments for its prevention.

Key Inclusion Criteria: Banked SCI tissue samples and healthy controls from MHH TMC inpatients

Enrollment Status: Actively enrolling

Contact Us: To learn more about this trial, please fill out this short online form »


Clinical Trials

Please fill out the fields to receive information about an ongoing UTHealth Neurosciences clinical trial.

  • This field is for validation purposes and should be left unchanged.